Pediatric Community Acquired Pneumonia, ED and Inpatient, Guideline

pediatric community acquired pneumonia pathway onepediatric community acquired pneumonia pathway twopediatric community acquired pneumonia pathway threepediatric community acquired pneumonia pathway fourpediatric community acquired pneumonia pathway fivepediatric community acquired pneumonia pathway sixpediatric community acquired pneumonia pathway seven

References

Bradley, J.S. et al. (2011). The management of community-acquired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines by the pediatric infectious disease society and the infectious disease society of America. Clinical Infectious Disease Advance Access. doi: 10.1093/cid/cir531

Cincinnati Children’s Hospital Medical Center (2012). Community-Acquired Pneumonia- Anti-Infective Selection from IDSA & BTS Guidelines, 1-6. Retrieved from https://www.cincinnatichildren... 

Dangerfield B, Chung A, Webb B, Seville MT. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia. Antimicrobial Agents and Chemotherapy. 2014;58(2):859-864. doi:10.1128/aac.01805-13

Neuman MI, Hall M, Lipsett SC, Hersh AL, Williams DJ, Gerber JS, Brogan TV, Blaschke AJ, Grijalva CG, Parikh K, Ambroggio L, Shah SS; Pediatric Research in Inpatient Settings Network. Utility of Blood Culture Among Children Hospitalized With Community-Acquired Pneumonia. Pediatrics. 2017 Sep;140(3):e20171013. doi: 10.1542/peds.2017-1013. Epub 2017 Aug 23. PMID: 28835382; PMCID: PMC5574722.

Seattle Children’s Hospital. (2016). Community- acquired pneumonia clinical practice guideline. Retrieved from https://www.seattlechildrens.o...